J7190 Factor viii
Also known as: Factor VIII, cryoprecipitate, FVIII concentrate
Injection of Factor VIII (antihemophilic factor), a coagulation factor used for replacement therapy in hemophilia A deficiency.
In Plain Language
clotting factor replacement; hemophilia A treatment
Clinical Context
Used for treatment and prophylaxis of bleeding in patients with hemophilia A or Factor VIII deficiency from any source.
RVU Information
CPT J7190 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J7190?
CPT J7190 (Factor viii) is a J Codes (Drugs) code. Injection of Factor VIII (antihemophilic factor), a coagulation factor used for replacement therapy in hemophilia A deficiency.
How is J7190 administered?
CPT J7190 is administered by a healthcare provider, typically via injection or infusion. Used for treatment and prophylaxis of bleeding in patients with hemophilia A or Factor VIII deficiency from any source. It is used by Hematology, Hemophilia Specialty Clinic, Critical Care.
When is CPT J7190 used?
Used for treatment and prophylaxis of bleeding in patients with hemophilia A or Factor VIII deficiency from any source.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.